ABC00226WY

Atorvastatin 3-Fluoro Analog

Atorvastatin 3-Fluoro Analog is a structurally modified derivative of atorvastatin, featuring a fluorine atom substituted at the 3-position of the phenyl ring. This substitution alters the electronic and steric properties of the parent molecule, impacting its metabolic stability and pharmacokinetic profile. The compound retains the core pyrrole-lactone scaffold and the hydroxymethyl group essential for HMG-CoA reductase interaction. Its fluorinated aromatic ring introduces a unique dipole moment, enhancing differentiation from related impurities via chromatographic methods. This compound serves as a critical HPLC reference standard for quantifying process-related impurities in atorvastatin formulations.

On Request
Molecular Formula C33H34FN2NaO5
Molecular Weight 580.6000
CAS Number 134523-01-6 โœ“ Verified
PubChem CID 23665101 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Atorvastatin
Lead Time On Request
IUPAC Name sodium (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate

๐Ÿ“ Synonyms

Atorvastatin sodium 134523-01-6 atorvastatin sodium salt UNII-DN43058TIV DN43058TIV ATORVASTATIN SODIUM [WHO-DD] ATORVASTATIN SODIUM SALT [MI] RefChem:115450 Atorvastatin (sodium) (3R,5R)-Atorvastatin Sodium Salt

๐Ÿ”ฌ Chemical Identifiers

CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Na+]
InChI=1S/C33H35FN2O5.Na/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;+1/p-1/t26-,27-;/m1./s1
VVRPOCPLIUDBSA-CNZCJKERSA-M

Related Products